Acute estradiol treatment reduces skeletal muscle protein breakdown markers in early- but not late-postmenopausal women

OBJECTIVES: Menopause and decline in estradiol (E(2)) may contribute to sarcopenia (i.e., age-related decline in muscle mass and strength) in women. E(2) may directly impact skeletal muscle protein breakdown via estrogen receptor (ER) signaling, primarily ERα. It is not yet known whether: 1) E(2) re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Steroids
Autors principals: Park, Young-Min, Keller, Amy C, Runchey, Shauna S, Miller, Benjamin F, Kohrt, Wendy M, Van Pelt, Rachael E, Kang, Chounghun, Jankowski, Catherine M, Moreau, Kerrie L
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679593/
https://ncbi.nlm.nih.gov/pubmed/30928279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.steroids.2019.03.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars